Stephen D. Griffin Vse Corp (VSEC) insider trading activity

Stephen D. Griffin is Senior Vice President and CFO of VSE CORP. Currently has a direct ownership of 28,763 shares of VSEC, which is worth approximately $2.54 Million. The most recent transaction as insider was on Apr 01, 2024, when has been sold 1,160 shares (Common Stock, par value $.05) at a price of $79.02 per share, resulting in proceeds of $91,663. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.8K

0% 3M change

53.34% 12M change

Total Value Held $2.54 Million

Stephen D. Griffin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Payment of exercise price or tax liability	$91,663 $79.02 p/Share	1,160 Reduced 3.88%	28,763 Common Stock, par valu...
Mar 31 2024	BUY Exercise of conversion of derivative security	-	1,287 Added 4.12%	29,923 Common Stock, par valu...
Mar 31 2024	BUY Grant, award, or other acquisition	-	2,567 Added 8.23%	28,636 Common Stock, par valu...
Mar 11 2024	SELL Payment of exercise price or tax liability	$227,688 $75.12 p/Share	3,031 Reduced 10.42%	26,069 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	1,324 Added 4.63%	27,279 Common Stock
Mar 11 2024	BUY Grant, award, or other acquisition	-	1,821 Added 5.89%	29,100 Common Stock
Mar 10 2024	BUY Grant, award, or other acquisition	-	5,132 Added 16.51%	25,955 Common Stock

Mar 10 2024	BUY Exercise of conversion of derivative security	-	1,832 Added 8.09%	20,823 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$10,978 $47.12 p/Share	233 Added 1.21%	18,991 Common Stock, par valu...
Jun 30 2023	BUY Grant, award, or other acquisition	$10,990 $41.01 p/Share	268 Added 1.41%	18,758 Common Stock, par valu...
Mar 31 2023	SELL Payment of exercise price or tax liability	$36,548 $44.9 p/Share	814 Reduced 4.22%	18,490 Common Stock, par valu...
Mar 31 2023	BUY Grant, award, or other acquisition	-	1,416 Added 6.83%	19,304 Common Stock, par valu...
Mar 31 2023	BUY Exercise of conversion of derivative security	-	1,288 Added 6.72%	17,888 Common Stock, par valu...
Mar 13 2023	SELL Payment of exercise price or tax liability	$38,779 $40.95 p/Share	947 Reduced 5.4%	16,600 Common Stock, par valu...
Mar 11 2023	BUY Grant, award, or other acquisition	-	1,820 Added 9.4%	17,547 Common Stock, par valu...
Mar 11 2023	BUY Exercise of conversion of derivative security	-	1,324 Added 7.76%	15,727 Common Stock, par valu...
Mar 10 2023	SELL Payment of exercise price or tax liability	$844 $42.23 p/Share	20 Reduced 0.14%	14,403 Common Stock, par valu...
Mar 10 2023	BUY Grant, award, or other acquisition	-	66 Added 0.46%	14,423 Common Stock, par valu...
Dec 30 2022	BUY Grant, award, or other acquisition	$4,555 $32.31 p/Share	141 Added 0.97%	14,357 Common Stock, par valu...
Nov 09 2022	SELL Payment of exercise price or tax liability	$73,101 $48.54 p/Share	1,506 Reduced 9.58%	14,216 Common Stock, par valu...
Nov 09 2022	BUY Grant, award, or other acquisition	-	5,000 Added 24.13%	15,722 Common Stock, par valu...
Jun 30 2022	BUY Grant, award, or other acquisition	$10,682 $33.07 p/Share	323 Added 2.92%	10,722 Common Stock, par valu...
Mar 31 2022	SELL Payment of exercise price or tax liability	$35,812 $46.09 p/Share	777 Reduced 6.95%	10,399 Common Stock, par valu...
Mar 31 2022	BUY Grant, award, or other acquisition	-	1,328 Added 10.62%	11,176 Common Stock, par valu...
Mar 31 2022	BUY Exercise of conversion of derivative security	-	1,288 Added 11.57%	9,848 Common Stock, par valu...

Also insider at

ANIK

Anika Therapeutics, Inc. Healthcare

EVP, CFO and Treasurer

SDG